SCRI Oncology Partners - PPDS
Nashville, Tennessee 37203
1 studies enrolling now · 2 studies all time
What they study most
EGFR/HER2 Exon 20 Insertion Mutation, Locally Advanced, Metastatic Cancers, NSCLC, Non-Small Cell Lung Cancer, Relapsed/Refractory Lymphomas, Unresectable